Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Irbesartan

U.S. FDA Requirements: Irbesartan

Pharmaceutical / Drug Definition : Blocks aldosterone-secreting and potent vasoconstrictive effects of angiotensin II at tissue receptor sites, which reduces vasoconstriction and lowers blood pressure

Registrar Corp assists Irbesartan companies with:

  • FDA Registration Irbesartan
  • FDA Listing Irbesartan
  • FDA Label Requirements and Exceptions Irbesartan
  • FDA Import Information Irbesartan
  • FDA Detentions Irbesartan (Irbesartan Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Irbesartan (Irbesartan Suppliers)
       - Processors Irbesartan
       - Repackers Irbesartan
       - Relabelers Irbesartan
       - Exporters Irbesartan
       - Importers Irbesartan
For more information about Irbesartan, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco